It works, it will get approved eventually. Maybe next week.
@dachopper "eventually & maybe" I'm certainly expecting a fair and just outcome by the FDA on 3 August 2023 as Remestemcel-L is safe, has a high percentage of success and there's limited alternatives. Remestemcel-L is a must treatment for those in despair it provides hope and the FDA will be hard pressed knocking this back considering the previous 9:1 vote and additional supporting data available.
It works, it will get approved eventually. Maybe next...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
-0.030(2.82%) |
Mkt cap ! $1.181B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.03 | $4.577M | 4.376M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 108887 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 22081 | 7 |
View Market Depth
| Last trade - 12.42pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.03 |
Change
-0.030 ( 3.65 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.03 | 1089509 | ||
| Last updated 13.01pm 06/06/2024 ? | |||||
| MSB (ASX) Chart |